Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study evaluated the safety and effectiveness of Esketamine for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including San Diego
A Multicenter, Exploratory, Randomized, Double-Arm, 4-week Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia
This study has finished and is no longer accepting participants.
In New YorkA Sequential Groups, Open Label, Rising Multiple Dose Study to Assess the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedA Multiple Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Subjects, Subjects With Generalized Anxiety Disorder (GAD) and Subjects With Bipolar Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Los Alamitos
The Influence of Specific Targeted Therapy on Subject and Family Quality of Life, Anxiety, Depression and Sleep Quality in Patients With Severe Refractory Atopic Dermatitis in the Czech Republic
This study has finished and is no longer accepting participants.
In Prague
A Randomized, Double Blind Controlled Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic for Individuals With Suicidal Ideation and/or Suicide Attempts
This study ended early.
Multiple locations, including DenverA Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder
Read the official source — NCT00035802Researchers compared Topiramate and placebo to find out how the approaches affected manic symptoms in young people with bipolarity type I.
This study has finished and is no longer accepting participants.
Location not clearly listedResearchers compared BIIB104 and placebo to find out how the approaches affected memory, attention and other thinking skills in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BentonvilleA Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia
Read the official source — NCT00250575This study evaluated the safety and effectiveness of Clozapine for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including ChibaA Double-Blind, Doubly-Randomized, Placebo-Controlled Study of Intranasal Esketamine in an Adaptive Treatment Protocol to Assess Safety and Efficacy in Treatment-Resistant Depression (SYNAPSE)
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamResearchers are comparing PF-04958242 and placebo to find out how the approaches affect memory, attention and other thinking skills in people with schizophrenia.
This study ended early.
Multiple locations, including Garden GroveEvaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
This study has finished and is no longer accepting participants.
Multiple locations, including San FranciscoWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.